CanniMed Therapeutics Inc operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares CanniMed Therapeutics Inc with three other
pharmaceutical manufacturers in North America:
Enzon Pharmaceuticals, Inc.
of the United States
sales of $8.38 million
Golden Leaf Holdings Ltd
(10.12 million Canadian Dollars [US$8.14 million]
based in the United States
of which 100%
was Therapeutic Drug Dev).